Articles by S Chanock (3)

Genetic Variations in the Sonic Hedgehog Pathway Affect Clinical Outcomes in Non-Muscle-Invasive Bladder Cancer

M Chen, M. A. T Hildebrandt, J Clague, A. M Kamat, A Picornell, J Chang, X Zhang, J Izzo, H Yang, J Lin, J Gu, S Chanock, M Kogevinas, N Rothman, D. T Silverman, M Garcia Closas, H. B Grossman, C. P Dinney, N Malats and X. Wu

Cancer Prevention Research 3 ( 10 ): 1235 - 1245 , 2010

Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study

H Song, S. J Ramus, S. K Kjaer, R. A DiCioccio, G Chenevix Trench, C. L Pearce, E Hogdall, A. S Whittemore, V McGuire, C Hogdall, J Blaakaer, A. H Wu, D. J Van Den Berg, D. O Stram, U Menon, A Gentry Maharaj, I. J Jacobs, P. M Webb, J Beesley, X Chen, The Australian Ovarian Cancer Study Group the Australian Cancer (Ovarian) Study, J. A Doherty, J Chang Claude, S Wang Gohrke, M. T Goodman, G Lurie, P. J Thompson, M. E Carney, R. B Ness, K Moysich, E. L Goode, R. A Vierkant, J. M Cunningham, S Anderson, J. M Schildkraut, A Berchuck, E. S Iversen, P. G Moorman, M Garcia Closas, S Chanock, J Lissowska, L Brinton, H Anton Culver, A Ziogas, W. R Brewster, B. A.J Ponder, D. F Easton, S. A Gayther, P. D.P Pharoah and on behalf of the Ovarian Cancer Association Consortium (OCAC)

Human Molecular Genetics 18 ( 12 ): 2297 - 2304 , 2009

Risk of Estrogen Receptor-Positive and -Negative Breast Cancer and Single-Nucleotide Polymorphism 2q35-rs13387042

R. L Milne, J Benitez, H Nevanlinna, T Heikkinen, K Aittomaki, C Blomqvist, J. I Arias, M. P Zamora, B Burwinkel, C. R Bartram, A Meindl, R. K Schmutzler, A Cox, I Brock, G Elliott, M. W. R Reed, M. C Southey, L Smith, A. B Spurdle, J. L Hopper, F. J Couch, J. E Olson, X Wang, Z Fredericksen, P Schurmann, M Bremer, P Hillemanns, T Dork, P Devilee, C. J van Asperen, R. A. E. M Tollenaar, C Seynaeve, P Hall, K Czene, J Liu, Y Li, S Ahmed, A. M Dunning, M Maranian, P. D. P Pharoah, G Chenevix Trench, J Beesley, kConFab Investigators, N. N Antonenkova, I. V Zalutsky, H Anton Culver, A Ziogas, H Brauch, C Justenhoven, Y. D Ko, S Haas, P. A Fasching, R Strick, A. B Ekici, M. W Beckmann, G. G Giles, G Severi, L Baglietto, D. R English, O Fletcher, N Johnson, I dos Santos Silva, J Peto, C Turnbull, S Hines, A Renwick, N Rahman, B. G Nordestgaard, S. E Bojesen, H Flyger, D Kang, K. Y Yoo, D. Y Noh, A Mannermaa, V Kataja, V. M Kosma, M Garcia Closas, S Chanock, J Lissowska, L. A Brinton, J Chang Claude, S Wang Gohrke, C. Y Shen, H. C Wang, J. C Yu, S. T Chen, M Bermisheva, T Nikolaeva, E Khusnutdinova, M. K Humphreys, J Morrison, R Platte, D. F Easton and on behalf of the Breast Cancer Association Consortium

JNCI J Natl Cancer Inst 101 ( 14 ): 1012 - 1018 , 2009